#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell small lymphocytic lymphoma recurrent Bronchopulmonary aspergillosis Follicular lymphoma stage I Aspergillus infection Hyperphagia Erythema multiforme Epilepsy Giant cell tumour of tendon sheath Cystic fibrosis gastrointestinal disease Drug eruption Autologous haematopoietic stem cell transplant Chronic lymphocytic leukaemia recurrent Frostbite Splenic marginal zone lymphoma Postprandial hypoglycaemia More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis – Trials in Disease Soft tissue sarcoma – Trials in Disease Von Willebrand’s disease – Basic Information Medulloblastoma recurrent – Treatment Thrombotic thrombocytopenic purpura – Treatment Progressive multifocal leukoencephalopathy – Diagnostics Myelodysplastic syndrome with excess blasts – Life with Disease Stevens-Johnson syndrome – Treatment Congenital nephrogenic diabetes insipidus – Life with Disease Cytokine release syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Miransertib Ezetimibe Azetukalner Intestifix Adagrasib Ads-013 IHMA-2121908-1 Pyridoxine Mva-209-Fsp-B1 Lorazepam Prx005 Apremilast Thiamine Nitrate TEDUGLUTIDE Rasburicase Temsirolimus Ibutamoren Mesilate Arachis Hypogaea (762) Bms-986435 Cobicistat More therapies…

    Learn about Your Condition

    Transplantation complication Meningioma malignant Anorexia nervosa Atrial flutter Malformation venous Eyelid ptosis Post cardiac arrest syndrome Hodgkin's disease recurrent Coronary artery bypass Fallopian tube cancer stage IV Peritoneal dialysis Food allergy Systemic candida Malabsorption Hyperhidrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune System Diseases

  • Safety and Efficacy of BMS-986528 with Tocilizumab in Patients with Refractory Rheumatoid Arthritis: A Phase 1/2a Open‑Label Study

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Tocilizumab
    Germany Italy Poland Spain

  • Study of Benralizumab Safety, Pharmacokinetics, and Efficacy in Children with Eosinophilic Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Eosinophilic granulomatosis with polyangiitis
    • Hypereosinophilic syndrome
    Investigated Drugs:
    • Benralizumab
    France The Netherlands Poland

  • Safety and Feasibility of Home Use On-Body Injection System for Subcutaneous Ocrelizumab in Adults with Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    France Italy Poland Spain

  • Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • C3 glomerulopathy
    • Glomerulonephritis membranoproliferative
    Investigated Drugs:
    • Pegcetacoplan
    France Germany Italy Spain

  • Discontinuation of methotrexate (drug combination) in rheumatoid arthritis patients using TNF inhibitors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Certolizumab Pegol
    • Leflunomide
    • Methotrexate Disodium
    The Netherlands

  • A Phase 2a Study of ly4005130 in Adults with Severe Alopecia Areata

    Recruiting

    2 1
    The Netherlands Poland
1 2 3 … 130
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!